Announcements Trials
Browse Landscape

Phase

Phase 2 187Phase 3 90Phase 1 69Phase 1/2 56Phase 4 9Phase 2/3 5Phase NA 4Phase EARLY_PHASE1 4

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 4Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 4Immunoglobulin Light-chain Amyloidosis 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Waldenstrom Macroglobulinemia 1Plasmacytoma 1Noninsulin-dependent diabetes mellitus with deafness 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Intraocular Lymphoma 1Burkitt Lymphoma 1Amyloidosis 1

Interventions

Cyclophosphamide 18fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 13Cyclosporine 12Whole-Body Irradiation 11Antilymphocyte Serum 10fludarabine 9Exercise 9Busulfan 9Mycophenolic Acid 8Melphalan 8Dexamethasone 8Blood Specimen Collection 8Filgrastim 7Standard of Care 6Radiotherapy 6Behavior Therapy 6Acupuncture Therapy 6Therapeutics 5Specimen Handling 5Palliative Care 5Methotrexate 5Granulocyte Colony-Stimulating Factor 5Etoposide 5Educational Status 5Surveys and Questionnaires 4Stem Cell Transplantation 4Psychiatric Rehabilitation 4Practice Guidelines as Topic 4Methylprednisolone 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Multiple Myeloma × Bortezomib × Clear all
NCT06203145 2024-01-12

A Clinical Study on the Whole-course Management (BCD-KPD-AutoHSCT) Scheme for Patients With RIMM

Peking University First Hospital

Phase NA Unknown
30 enrolled
Plasma cell

Multiple Myeloma

NCT02037256 2021-05-10

Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma

Barbara Ann Karmanos Cancer Institute

Phase NA Completed
23 enrolled 8 charts
LymphoidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Intraocular Lymphoma

NCT00135187 2012-02-07

Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma

University of Michigan Rogel Cancer Center

Phase NA Completed
30 enrolled
Plasma cell

Multiple Myeloma

NCT00569868 2011-08-12

UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma

University of Arkansas

Phase NA Completed
11 enrolled 4 charts
Plasma cell

Multiple Myeloma, Plasmacytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡